Evidence map›Paper›PMID 30169837›Full record

ArticleJournal of the Pediatric Infectious Diseases Society2019

Human Immunodeficiency Virus (HIV)-Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children.

Salvatore Rocca, Paola Zangari, Nicola Cotugno, Anita De Rossi, Bridget Ferns, Davide Petricone, Stefano Rinaldi, Carlo Giaquinto, Stefania Bernardi, Pablo Rojo and 5 more

Abstract read
In one paragraph

Article in Journal of the Pediatric Infectious Diseases Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Salvatore RoccaDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Paola ZangariResearch Unit in Congenital and Perinatal Infection, Immune and Infectious Diseases Division, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, Rome, Italy.
Nicola CotugnoDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Anita De RossiSection of Oncology and Immunology, DiSCOG, University of Padova, Italy; 3bis Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV)-IRCCS, Padova, Italy.
Bridget FernsVirology Laboratory, Clinical Microbiology and Virology, University College London Hospital NHS Foundation Trust, London, United Kingdom.
Davide PetriconeDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Stefano RinaldiDepartment of Microbiology and Immunology, Miller School of Medicine, University of Miami, Florida.
Carlo GiaquintoDepartment of Women's and Children's Health, University of Padova, Italy.
Stefania BernardiAcademic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital-University of Rome Tor Vergata, Italy.
Pablo RojoDepartment of Pediatrics, Pediatric Infectious Diseases Unit, Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain.
Paolo RossiDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Savita PahwaDepartment of Microbiology and Immunology, Miller School of Medicine, University of Miami, Florida.
Eleni NastouliVirology Laboratory, Clinical Microbiology and Virology, University College London Hospital NHS Foundation Trust, London, United Kingdom.
Paolo PalmaResearch Unit in Congenital and Perinatal Infection, Immune and Infectious Diseases Division, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, Rome, Italy.
EPIICAL Consortium

Funding

WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Sharon L. Hillier, JONATHAN KARN · 1994 to 2026
$50.0M
University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ALLAN E RODRIGUEZ · 2007 to 2026
$33.8M
Immunity and HIV persistence in perinatal HIV infectionR01AI127347 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PAHWA, SAVITA · 2016 to 2020
$3.3M
NIAID NIH HHS P30 AI036219NIAID NIH HHS P30 AI073961NIAID NIH HHS R01 AI127347
6 · The paper itself

Abstract

backgroundAssays to estimate human immunodeficiency virus (HIV) reservoir size require large amounts of blood, which represents a drawback especially in pediatric settings. We investigated whether HIV-antibody repertoire could estimate the viral reservoir size. Moreover, we assessed the magnitude of HIV-antibody response as a predictor of time of antiretroviral therapy (ART) initiation.

methodsHuman immunodeficiency virus-antibody responses to 10 different viral proteins were evaluated by HIV Western blot (WB) kit and a WB score was assigned to each patient. Patients were classified in 2 subgroups based on the timing of ART initiation (early treated [ET], 0-24 weeks and late treated [LT], >24 weeks). Human immunodeficiency virus-deoxyribonucleic acid (DNA) was quantified using real-time quantitative polymerase chain reaction on total peripheral blood mononuclear cells. Logistic regression and principal component analysis were built on these data to test the ability of WB score to predict the expected value of HIV-DNA and the timing of ART initiation.

resultsSixty-nine perinatally HIV-infected children were evaluated. Reduced HIV-specific antibody responses and lower size of HIV-DNA were observed in ET compared with LT patients (P < .001 and P = .02, respectively). We found that WB score correlates with HIV-DNA (P = .032) and timing of ART initiation (P < .001). Based on the logistic regression analysis, we found that WB score can predict the HIV-DNA size and the timing of ART initiation with an Akaike information criterion of -118.13 and -151.51, respectively.

conclusionsWestern blot score can estimate HIV-DNA size and timing of ART initiation in long-term virally suppressed children. This rapid, inexpensive, and easily reproducible tool can provide useful information to identify potential candidates for HIV remission studies.

Indexed as

AdolescentAnti-HIV AgentsBlotting, WesternChildChild, PreschoolCohort StudiesDNA, ViralDrug Administration ScheduleFemaleHIVHIV AntibodiesHIV InfectionsHIV SeronegativityHIV SeropositivityHumansInfantAnti-HIV AgentsDNA, ViralHIV Antibodieschildrenearly antiretroviral therapyHIV-antibody repertoireHIV reservoirserology

Identifiers

PMID30169837
PMCPMC6831830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.